1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Skin Cancer Diagnostics Market – By Type

1.3.2        North America Skin Cancer Diagnostics Market – By Screening Type

1.3.3        North America Skin Cancer Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Skin Cancer Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America– PEST Analysis

4.3         Expert Opinion

5.           Skin Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Incidence of Skin Cancer

5.1.2        Launch of New Skin Cancer Diagnostics Products

5.2         Market Restraints

5.2.1        Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries

5.3         Market Opportunities

5.3.1        Government Support for Early Skin Cancer Diagnosis

5.4         Future Trends

5.4.1        Skin Cancer Diagnostics Through AI

5.5         Impact Analysis

6.           Skin Cancer Diagnostics Market – North America Analysis

6.1         North America Skin Cancer Diagnostics Market Revenue Forecast and Analysis

7.           Skin Cancer Diagnostics Market Analysis – By Type

7.1         Overview

7.2         Skin Cancer Diagnostics Market Revenue Share, by Type (2020 and 2028)

7.3         Melanoma

7.3.1        Overview

7.3.2        Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Non-melanoma

7.4.1        Overview

7.4.2        Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Skin Cancer Diagnostics Market – By Screening Type

8.1         Overview

8.2         Skin Cancer Diagnostics Market, by Screening Type, 2020 and 2028 (%)

8.3         Blood Tests

8.3.1        Overview

8.3.2        Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Dermatoscopy

8.4.1        Overview

8.4.2        Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Imaging Tests

8.5.1        Overview

8.5.2        Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Lymph Node Biopsy

8.6.1        Overview

8.6.2        Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Skin Biopsy

8.7.1        Overview

8.7.2        Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Skin Cancer Diagnostics Market – Regional Analysis

9.1         North America: Skin Cancer Diagnostics Market

9.1.1        Overview

9.1.2        North America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.3        North America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.4        North America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)

9.1.5        North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.1.5.1          US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.1.1          US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.1.2          US: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.1.3          US: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.1.5.2          Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.2.1          Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.2.2          Canada: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.2.3          Canada: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.1.5.3          Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.3.1          Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.3.2          Mexico: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.3.3          Mexico: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

10.        Skin Cancer Diagnostic Market–Industry Landscape

10.1      Overview

10.2      Growth Strategies in the Skin Cancer Diagnostic Market (%)

10.3      Organic Developments

10.3.1     Overview

10.4      Inorganic Developments

10.4.1     Overview

11.        Company Profiles

11.1      SkylineDx BV

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     SWOT Analysis

11.1.5     Key Developments

11.2      AMLo Biosciences Limited

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     SWOT Analysis

11.2.5     Key Developments

11.3      DermLite LLC

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      bioMerieux SA

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Veriskin Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Castle Biosciences, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      DermTech Inc

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      HOFFMANN-LA ROCHE LTD.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.9      Michelson Diagnostics Ltd.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             North America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             US: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Canada: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Canada: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Mexico: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Mexico: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Organic Developments in the Skin Cancer Diagnostic Market

Table 10.          Inorganic Developments in the Skin Cancer Diagnostics Market

Table 11.          Glossary of Terms, Skin Cancer Diagnostics Market

LIST OF FIGURES

Figure 1.           Skin Cancer Diagnostics Market Segmentation

Figure 2.           North America Skin Cancer Diagnostics Market Overview

Figure 3.           Non-Melanoma Segment Held Largest Share of Type Segment in Skin Cancer Diagnostics Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Skin Cancer Diagnostics Market, Industry Landscape

Figure 6.           North America PEST Analysis

Figure 7.           Skin Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.           North America Skin Cancer Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Skin Cancer Diagnostics Market Revenue Share, by Type (2020 and 2028)

Figure 10.        Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Skin Cancer Diagnostics Market, by Screening Type, 2020 and 2028 (%)

Figure 13.        Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America: Skin Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 19.        North America: Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 20.        North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 21.        US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 24.        Growth Strategies in the Skin Cancer Diagnostic Market (%)